氨基西林, gemifloxacin 和 rabeprazole,作为临床实践中的一线Helicobacter pylori疗法:一个试点研究
Guner Kilic1, Gulce Ecem Kilic2, Adnan Özkahraman2
1Van Training and Research Hospital, Department of Internal Medicine, Division of Gastroenterology, Van, Turkey.
Medicine
|May 3, 2024
概括
这项研究表明,结合阿莫西西林,吉米弗洛克萨和拉贝普拉的7天治疗有效地消除了H. pylori在91.3%的患者中. 该疗法显示出高疗效和良好的耐受性,为H. pylori感染治疗提供了一个有前途的选择.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于抗生素耐药性增加,Helicobacter pylori (H. pylori) 的根除率正在下降.
- 对H. pylori的标准多药疗法可能会导致显著的副作用,降低患者的服药量.
- 需要新的治疗策略来克服耐药性和改善治疗坚持.
研究的目的:
- 评估H. pylori根除组合疗法的疗效,可靠性和副作用概况.
- 评估包括阿莫西西林,吉米弗洛克萨辛 (新一代醇) 和拉贝普拉的治疗方案.
- 为了确定这种组合作为一线治疗选择的适用性.
主要方法:
- 总共有71名H. pylori-naive患者被纳入该研究.
- 治疗包括阿莫西西林 (1000毫克两次一天),吉米弗洛克萨辛 (320毫克四次一天) 和拉贝普拉 (20毫克两次一天) 持续7天.
- 治疗后一个月通过便H. pylori抗原测试来评估有效性;遵守性和耐受性也被评估.
主要成果:
- 在71名患者中,63名患者 (88.7%) 取得了成功的H. pylori根除.
- 除了两名因副作用或不服药而停止治疗的患者外,完成治疗的患者的根除率为91.3% (63/69).
- 在12.7%的患者中报告了不良事件,主要是轻微的胃肠道症状,如腹和膨胀;没有注意到严重的副作用.
结论:
- 阿莫西西林,吉米弗洛克萨和拉贝普拉的组合显示出H. pylori根除的高效率和良好的耐受性.
- 这种疗法是一种可行的和有效的第一线治疗选择,特别是在对克拉里菌素和甲尼达耐药性较高的地区.
- 良好的副作用概况支持其用于改善患者对H. pylori治疗的遵从性.
更多相关视频
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
311
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
234
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
379
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
379
01:26Peptic Ulcer Disease IV: Management
89
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
89
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
115
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
115
01:23Gastritis III: Clinical Manifestations and Management
232
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
232
01:30Peptic Ulcer Disease I: Introduction
165
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
165
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
432
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
432